Pulmonary diseases

09

Jul 2021

In June 2021, twelve clinical guidelines were released in Russia: perforated ulcer, bronchial asthma, multiple pregnancy, and others. Furthermore, the orders on the approval of the several standards of medical care entered into force, including standards for the provision of medical care for adults with ischemic heart disease, atrial fibrillation and flutter, and pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Read more

09

Jun 2021

For the first time in three years, the Institute for Quality and Efficiency in Health Care (IQWiG) received data within the framework of the early benefit assessment of new examination and treatment methods (NUB) with high-risk medical devices according to §137h of Social Code Book (SGB) V. This involves seven invasive therapeutic cardiovascular, pulmonary, neurological, gastrointestinal, and urological procedures. Read more

11

Feb 2021

On January 28, 2021, the Innovation Committee at the Federal Joint Committee (G-BA) published the first overview of the 28 innovative projects on new forms of medical care that will be funded. The projects concerning the technologies belonging to the cardiovascular, eHealth, orthopedic, neurology, nephrology, and other technology groups received funding. Read more

06

Aug 2020

On behalf of the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether (former) heavy smokers within statutory health insurance (SHI) should be offered lung cancer screening using low-dose computed tomography (LDCT). Read more

28

May 2020

On behalf of the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) has researched current evidence-based guidelines on the chronic obstructive pulmonary disease (COPD), summarized their recommendations and checked the need for updates for the COPD disease management program (DMP). Read more

04

May 2020

The revised EBM (German Uniform Evaluation Standard) catalog came into force on April 1, 2020. MTRC has compiled the selection of the most significant changes. Read more

21

Feb 2019

In early February 2019, the network of European HTA agencies, EUnetHTA, announced the final report of the project OTCA12 “C-reactive protein point-of-care testing (CRP POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections (RTIs)”. Read more